CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients
DOI 10.1055/s-0035-1551747
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Mandorfer, S Steiner, P Schwabl, MC Aichelburg, K Grabmeier-Pfistershammer, A Rieger, M Trauner, T Reiberger, M Peck-Radosavljevic
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Despite promising results for the combination of sofosbuvir and daclatasvir (SOF/DCV) in patients with HCV-monoinfection, there are currently no reports on its use in HIV/HCV-coinfected patients (HIV/HCV). Aim: To investigate the use of SOF/DCV in HIV/HCV, who have an urgent need for effective treatment options. Methods: The DCV dose was adjusted to the antiretroviral therapy, as recommended by the Europ…
Zitieren
Zitierempfehlung
M Mandorfer, S Steiner, P Schwabl, MC Aichelburg, K Grabmeier-Pfistershammer, A Rieger, M Trauner, T Reiberger, M Peck-Radosavljevic (2015) Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0035-1551747
Mit CareLit weiterarbeiten